Locations
England, UK · Oxford, UK · Oxfordshire, UK
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series B
founded in
2016
OMass Therapeutics is a drug discovery company focused on identifying new medicines for immunological and orphan diseases. Utilizing proprietary biochemistry techniques, native mass spectrometry, and custom chemistry, the company targets highly validated but inadequately drugged targets, such as membrane proteins and intracellular complexes. Their pipeline includes small molecule therapeutics aimed at solute carriers, inflammasome complexes, and GPCRs, positioning them uniquely in the market. With a well-financed operation based in Oxford, UK, OMass is backed by a top-tier investor syndicate, indicating strong traction and potential for growth in the biopharmaceutical sector.
Something looks off?On-site & Remote